Thoma Bravo completes take-private Imprivata acquisition

Thoma Bravo has closed its previously announced buy of healthcare IT security company Imprivata for $19.25 per share. As a result of the deal's completion, Imprivata stock will stop trading and be delisted from the New York Stock Exchange. Barclays provided financial advice to Imprivata on the transaction while Silicon Valley Bank arranged the debt financing.

DealsNorth AmericaUSBriefs